$214 Million is the total value of BOONE CAPITAL MANAGEMENT LLC's 12 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 64.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| UNM | Buy | UNUM GROUP | $33,925,271 | +23.1% | 857,565 | +27.7% | 15.88% | +12.3% |
| CI | Buy | THE CIGNA GROUP | $26,223,255 | +34.1% | 102,623 | +73.9% | 12.28% | +22.3% |
| MOH | Buy | MOLINA HEALTHCARE INC | $24,719,286 | +89.8% | 92,412 | +134.3% | 11.57% | +73.1% |
| DHR | Buy | DANAHER CORPORATION | $22,315,118 | +54.7% | 88,538 | +62.9% | 10.45% | +41.1% |
| AMGN | New | AMGEN INC | $19,134,513 | – | 79,150 | +100.0% | 8.96% | – |
| Buy | ENOVIS CORPORATION | $18,173,655 | +22.9% | 339,758 | +23.0% | 8.51% | +12.1% | |
| BIIB | Buy | BIOGEN INC | $16,548,902 | +42.8% | 59,522 | +42.3% | 7.75% | +30.3% |
| BAX | New | BAXTER INTL INC | $14,376,208 | – | 354,443 | +100.0% | 6.73% | – |
| ABBV | Buy | ABBVIE INC | $14,028,704 | +14.4% | 88,026 | +16.0% | 6.57% | +4.4% |
| CPSI | Buy | COMPUTER PROGRAMS & SYS INC | $10,547,199 | +70.4% | 349,245 | +53.6% | 4.94% | +55.4% |
| CERE | New | CEREVEL THERAPEUTICS HLDNG I | $7,317,000 | – | 300,000 | +100.0% | 3.42% | – |
| QTRX | Buy | QUANTERIX CORP | $6,324,093 | -6.9% | 561,144 | +14.5% | 2.96% | -15.0% |
| CSII | Exit | CARDIOVASCULAR SYS INC DEL | $0 | – | -99,157 | -100.0% | -0.69% | – |
| CABA | Exit | CABALETTA BIO INC | $0 | – | -266,882 | -100.0% | -1.27% | – |
| AFMD | Exit | AFFIMED N V | $0 | – | -2,869,744 | -100.0% | -1.83% | – |
| APEN | Exit | APOLLO ENDOSURGERY INC | $0 | – | -718,419 | -100.0% | -3.68% | – |
| MDRX | Exit | VERADIGM INC | $0 | – | -600,000 | -100.0% | -5.43% | – |
| ABT | Exit | ABBOTT LABS | $0 | – | -112,106 | -100.0% | -6.32% | – |
| OGN | Exit | ORGANON & CO | $0 | – | -498,262 | -100.0% | -7.14% | – |
| LLY | Exit | LILLY ELI & CO | $0 | – | -47,448 | -100.0% | -8.91% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| UNUM GROUP | 4 | Q3 2023 | 15.9% |
| THE CIGNA GROUP | 4 | Q3 2023 | 12.3% |
| MOLINA HEALTHCARE INC | 4 | Q3 2023 | 11.7% |
| DANAHER CORPORATION | 4 | Q3 2023 | 10.4% |
| ENOVIS CORPORATION | 4 | Q3 2023 | 9.8% |
| BIOGEN INC | 4 | Q3 2023 | 7.8% |
| QUANTERIX CORP | 4 | Q3 2023 | 4.9% |
| AMGEN INC | 3 | Q3 2023 | 9.0% |
| BAXTER INTL INC | 3 | Q3 2023 | 11.2% |
| ABBVIE INC | 3 | Q2 2023 | 6.6% |
View BOONE CAPITAL MANAGEMENT LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
View BOONE CAPITAL MANAGEMENT LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.